NewsBenzingaGuggenheim maintient sa recommandation d’achat sur MBX Biosciences et relève son objectif de cours à 150 $ Guggenheim maintient sa recommandation d’achat sur MBX Biosciences et relève son objectif de cours à 150 $ Benzinga 2026.10.02 13:05 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Maintains Hold on Skydance, Lowers Price Target to $8.5 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84